Children under the age of 12 will be involved in a new coronavirus vaccine study conducted by Pfizer.
The drugmaker says up to 45-hundred children will be enrolled and it will take place at more than 90 clinical sites around the world. Also, the dosage given to children will depend on their age. The U.S. currently allows children age 12 and over to get the Pfizer shots to protect themselves against the virus.
